Abstract
Introduction
The advantage of charged particles, in particular, protons and carbon nuclei, used for radiation therapy of cancer consists in elevated dose delivered at the end of projectile range in tissues. The plateau of the depth-dose distribution at the entrance of a monoenergetic beam terminates with a sharp Bragg peak which can be targeted at the tumor. Such a dose profile helps to spare healthy tissues located in front of the tumor as well as beyond the projectile range. Since a set of beam energies is typically used in treatments to cover the whole tumor volume, the resulting dose distribution is characterized by a spread-out Bragg peak (SOBP) [1, 2, 3] with a wide domain of elevated dose.
The damage of healthy tissues during therapy can be essentially reduced if the ratio between the relative biological effectiveness (RBE) values at the SOBP region and plateau is favorable. As recognized almost 40 years ago in radiobiological experiments with SOBP beams of light nuclei performed at Berkeley [4] , this RBE ratio is greater than 1 and increases with ion charge up to carbon. It was also found that this ratio decreases for Ne and becomes less than 1. In 1994 first patient treatments with beams of carbon nuclei started in Japan at National Institute of Radiological Sciences (NIRS) [5] and in 1997 in Germany at Gesellschaft für Schwerionenforschung (GSI) [3] . Later the advantages of 12 C with respect to 3 He and 20 Ne were confirmed in experiments at NIRS with these nuclear beams [6] . As explained [7] , the RBE of 135 MeV/u 12 C beam with the linear energy transfer (LET) of 65 keV/µm was found similar to the RBE of neutrons which have been used for treatment at NIRS during last 20 years. This similarity also motivated the choice of carbon nuclei for treatments at NIRS. In the last decades localized tumors have been successfully treated with beams of carbon nuclei at several facilities constructed in Japan and Germany [8, 9, 10, 11, 12, 13] .
Despite of the broad clinical experience collected worldwide with proton and carbon-ion beams, other light nuclei can be also considered as future therapy options. The radiobiological properties of proton and 12 C beams were compared in several studies, see e.g. [14, 15] . However, less attention has been paid so far to 4 He or 16 O and to their comparison with protons and 12 C. There exist several clinical rationale behind the use of 4 He and 16 O for therapy:
i) 4 He and 16 O beams have a reduced lateral spread of the dose distribution compared to protons;
ii) their RBE in the target volume is higher compared to protons;
iii) lower dose in the tail region and lower RBE in the plateau is expected for 4 He compared to 12 C due to reduced nuclear fragmentation of 4 He; iv) 16 O is a promising option for hypoxic tumors as it provides a higher dose averaged LET in the target volume compared to 12 C.
The choice of ion species and their energies at each new particle therapy facility [16, 17, 18] [21] with the Geant4 toolkit to study their dependence on the ions mass, charge and energy. It was assumed [19] that ions with LET above 20 keV/µm should be used for efficient cancer therapy as such species induce on average two and more double strand breaks in DNA close to each other. However, as pointed out in the same work, this limit is not sharp and ought to vary with ion mass and charge. This indicates that the RBE of respective ions has to be additionally considered for an accurate comparison of their biological action. Indeed, as shown in our recent work [22] , there is no direct correspondence between RBE and the frequency-mean linear energyȳ f , which represents LET, for monoenergetic beams of therapeutic energies. Similar RBE values were estimated [22] at the peak and plateau regions which are characterized, however, by very differentȳ f .
As demonstrated [22] , microdosimetry spectra for monoenergetic 1 H, 4 He, 7 Li and 12 C nuclei propagating in a water phantom can be accurately described with our Monte Carlo model for HeavyIon Therapy (MCHIT) [23] , and this model coupled with the Microdosimetric Kinetic (MK) model [24, 25] can be used to calculate the respective RBE profiles. In the present work we evaluate 4 He and 16 O for cancer therapy as complementary options to 1 H and 12 C by considering the biological dose distribution with a 6 cm SOBP delivered by these four projectiles. This is an important prerequisite for planning radiobiological experiments with 4 He and 16 O SOBP beams and extending existing treatment planning systems to operation with 4 He and 16 O. The experimental data [7] collected at HIMAC for the 6 cm SOBP obtained by the moderation of a 290 MeV/u 12 C beam are used as a reference. The results of microdosimetry simulations are validated by comparison with microdosimetry data collected for 1 H, 4 He and 12 C beams [25] . This makes possible to predict the RBE and cell survival profiles for 16 O beams and compare all four ion species in a common framework.
Materials and methods

Monte Carlo modeling of propagation of ions in water
With the Monte Carlo model for Heavy Ion Therapy (MCHIT) [26, 23] the propagation of accelerated protons and light nuclei of therapeutic energies in tissue-like media can be simulated. The model is based on the Geant4 toolkit [27, 28] and takes into account all major physics processes relevant to the interactions of beam particles with these materials. The Geant4 version 9.5 with patch 02 is used to build the present version of MCHIT, which also simulates the interactions of various particles with walled and wall-less Tissue Equivalent Proportional Counters (TEPC) thus providing respective microdosimetry distributions.
The ionization of atoms and multiple Coulomb scattering on nuclei of the media are the most important electromagnetic processes to simulate the energy loss and straggling of primary and secondary charged particles. Two predefined physics lists for electromagnetic processes are employed in MCHIT, namely, G4EmStd (which uses the "Standard Electromagnetic Physics Option 3") and G4EmPen (which uses the Penelope models for low-energy processes). The low-energy thresholds for production of δ-electrons are 990 eV for G4EmStd and 100 eV for G4EmPen. However, in order to reduce the CPU time, cuts in range and energy thresholds for particle production are set differently for water, plastic of the TEPC wall and the TEPC sensitive volume filled with tissue-equivalent gas [29] . A customized physics list, G4EmPen+IonGas, which is based on G4EmPen and the models describing the ionization of gas media by ions, can be also used in calculations. As demonstrated [22] , G4EmStd and G4EmPen provide statistically equivalent results for microdosimetry spectra, which agree well with the distributions measured for 4 He [30] , excluding the domains of low linear energy, y <1 keV/µm, and around the maximum at y ∼15 keV/µm. However, the agreement between the data and calculations is improved when G4EmPen+IonGas is used. Therefore, G4EmPen+IonGas is involved in MCHIT also in the present work to simulate electromagnetic processes inside the TEPC volume.
A therapeutic nuclear beam is attenuated in tissues due to the loss of beam nuclei in nuclear fragmentation reactions, which generate secondary projectile and target fragments [23] . Nuclear reactions are taken into account in MCHIT to reproduce this effect. As shown [23] , the build-up of secondary fragments produced by 200 MeV/u and 400 MeV/u 12 C beams is generally well described with a customized physics list based on the Light Ion Binary Cascade model (G4BIC) [31] coupled with the Fermi break-up model (G4FermiBreakUp) [32] responsible for subsequent decays of excited nuclear fragments created at the first fast stage of nucleus-nucleus collisions. In the present work G4BIC is used for proton, helium and lithium beams, while the Quantum Molecular Dynamics model (G4QMD) [33] is involved in simulations with carbon and oxygen beams. More details on the physics processes and respective Geant4 models involved in modeling with MCHIT are given in our recent publications [23, 29, 22 ].
Microdosimetry simulations and calculations of RBE for monoenergetic beams
The design and materials of specific TEPC models were thoroughly introduced in MCHIT. This made possible to simulate the microdosimetry spectra measured with a walled TEPC at several positions inside a water phantom irradiated by 185 MeV/u 7 Li and 300 MeV/u 12 C beams [34] and study the impact of nuclear fragmentation reactions on these spectra [29, 22] . The influence of the positioning of the TEPC with respect to the beam axis and the distortion of the spectra due to the pile-up of individual events were investigated. After correcting for such effects the calculated microdosimetry spectra agree well with the experimental data in general.
Following the validation of MCHIT for microdosimetry of monoenergetic 7 Li and 12 C beams [29, 22] , this model is applied to microdosimetry of SOBP dose distributions considered in the present work. In the measurements performed at HIMAC with a 6 cm SOBP for 160 MeV 1 H, 150 MeV/u 4 He and 290 MeV/u 12 C [25] the data for frequency-mean lineal energy,ȳ f , dose-mean lineal energy, y d , and saturation-corrected dose-mean lineal energy, y * [35] were collected. The microdosimetry spectra were measured with a walled TEPC corresponding to a tissue-equivalent sphere of 1 µm in diameter.
According to the linear-quadratic (LQ) model the fraction of cells S survived after the impact of the radiation dose D is calculated as
Following the modified MK model [25] applied to human salivary gland (HSG) tumor cells the parameter α is estimated as
with the constant term α 0 = 0.13 Gy −1 representing the initial slope of the survival fraction curve in the limit of zero LET and β = 0.05 Gy −2 , ρ =1 g/cm 3 as the density of tissue and r d =0.42 µm as the radius of a sub-cellular domain in the MK model. The dependence of the α-parameter of the linearquadratic model on y * rather than onȳ d reflects the reduction of the RBE known as the saturation effect. It means that an excessive local energy deposition does not boost biological effects induced by high-LET particles [35] . As demonstrated [25] , the same value of parameter β = 0.05 Gy −2 can be used to fit the data on S with Eq. (1) for X-rays and ions. This justifies the assumption of the MK model that β is independent of LET.
According to the LQ model the RBE 10 for 10% survival of HSG cells is calculated using the following relation [36] :
where D 10 is the 10% survival dose of ions and D 10,R = 5.0 Gy is the 10% survival dose of the reference radiation (200 kVp X-rays) for HSG cells [36] . Finally, the biological dose D bio is calculated from RBE 10 and physical dose:
Composing SOBP profiles from a library of pristine Bragg peaks
The computing time required for treatment planing in carbon-ion therapy can be reduced by using pre-computed libraries of dose and RBE distributions for monoenergetic beams [37, 38, 39] . The aim of the treatment planning is to find an optimum superposition of many beams with their individual energy, position and intensity in order to obtain the prescribed biological SOBP dose profile. It is expected that a similar approach will be also suitable for other therapeutic beams, like 4 He and 16 O. Therefore, we implemented a common algorithm to calculate the relative weights of pre-defined monoenergetic beams of 1 H, 4 He, 12 C and 16 O to obtain flat biological SOBP distributions for each projectile as a product of the physical dose and RBE calculated for mixed radiation field.
A library of depth-dose profiles and the corresponding microdosimetry spectra for different beam energies and nuclei were calculated by Monte Carlo simulations with MCHIT. They are used as input data for a procedure similar to one implemented at NIRS [7] . According to this procedure based on the theory of dual radiation action [40] the survival fraction of cells exposed to mixed radiation is calculated as:
Here f i is the weight coefficient (fraction) of the local physical dose of the ith monoenergetic beam which contribute to the total physical dose D, while α i and β i are the parameters of the LQ model specific to ith monoenergetic beam. The parameters α i and β i are calculated along the beam axis using MCHIT coupled with the modified MK model as described in Sec. 2.2. The resulting RBE 10,mix for the mixed radiation is calculated from the survival fraction of cells S mix (D) and it also depends on the depth. RBE 10 and RBE 10,mix for the monoenergetic and SOBP (mixed) beams, respectively, are considered in the following. They account for the relative biological effectiveness corresponding to 10% survival of cells. A dedicated algorithm to obtain f i for a given biological SOBP was developed. It starts with the determination of the weight at the distal edge of the SOBP distribution and then calculates weights for less energetic beams by adjusting their contribution to provide a flat SOBP plateau. Figure 1 and they differ from each other. The RBE 10 for 12 C beam estimated from the parameters of a LQ fitting on survival curves of HSG cells with β fixed to 0.05 Gy −2 [25] is presented for comparison. The RBE 10 profile for 12 C beam calculated with MCHIT coupled with the MK model agrees well with the profile which is also calculated with MK, but using the measured microdosimetry data on y * [25] . A prominent difference between RBE 10 profiles for 12 C and 16 O and the profile for 4 He is seen in the insert of Figure 1 [25] are shown by circles. The RBE 10 estimated from LQ fitting on survival curves of HSG cells [25] are presented by triangles. The biological dose distributions for all ions were rescaled to get the same value at the maximum. the position of the 4 He maximum is due to the saturation effect. It is also found that 12 C and 16 O nuclei are characterized by higher RBE values for 10% survival of HSG cells along the whole irradiated medium. Their maximum values reach 2.9 and 3.1, respectively, close to the Bragg peak. At the same time the RBE 10 values for helium are relatively low at the entrance and tail regions and demonstrate a steep rise to 2.2 at the Bragg peak position. Before the Bragg peak the RBE 10 values for proton beam are slightly below 1. and increase to 1.5 well after the distal edge of the proton Bragg peak. This rise of RBE 10 for proton beam is explained by the presence of secondary nucleons produced by beam protons in water and propagating beyond the Bragg peak.
Finally, the biological dose profiles for 1 H, 4 He, 12 C and 16 O (a.u.) are presented in the bottom panel of Figure 1 . They were rescaled to get the same value at the maximum. The profiles for 4 He, 12 C and 16 O are very similar to each other. They are characterized by a more sharp rise and fall of the biological dose in the Bragg peak region compared to protons. After renormalization lower biological dose for 4 He, 12 C and 16 O is predicted at the entrance with respect to protons. SOBP profiles of biological dose for all these projectiles are considered below.
RBE distributions for
As explained in Sec. 2.3, a given biological SOBP dose distribution is composed from a set of depthdose and depth-y * profiles calculated with MCHIT for monoenergetic beams. Such a library created in the present work contains pristine Bragg curves with a 1 mm increment of the Bragg peak positions which are within 90-175 mm depth in water. Seven pristine Bragg peaks for 12 C covering a 60 mm domain in depth are shown in Figure 2 to illustrate the content of this library. The microdosimetry variables which are also stored in the library as functions of depth are used to estimate RBE 10 profiles according to the MK model, see Sec. 2.3. The respective RBE 10 distributions are shown in Figure 2 for the same beams. As seen in Figure 2 , the height of the Bragg peak noticeably diminishes with depth, while the maximum RBE 10 remains almost constant (∼ 3) over the considered depth range. A 6 cm-wide SOBP profile of biological dose for 290 MeV/u 12 C beam, which was built according to the above-described procedure is shown in the top panel of Figure 3 . Here and in the following such profiles are normalized to 1 at the plateau in order to facilitate the comparison of various ion species. The resulting distribution has a flat SOBP plateau with negligible fluctuations due to the presence of individual Bragg peaks. In contrast, the corresponding SOBP distribution of the physical dose, which is also shown in Figure 3 is not flat, but rather decreases with depth. The respective RBE 10 amounts to ∼ 1.6 at the proximal edge of the SOBP, while it is slightly above 2.5 at the distal edge, see the bottom panel of Figure 3 . The insert in the bottom panel of Figure 3 demonstrates the calculated relative weights for monoenergetic beams used to build the SOBP distribution of biological dose shown in Figure 3 .
The 6 cm-wide RBE 10,mix profiles calculated for HSG cells for 152. Figure 4 . They were calculated within the MK model basing on microdosimetry data generated by Monte Carlo simulations with MCHIT. The reliability of these profiles can be proved by comparing them with RBE 10,mix calculated by two different approaches. In the first case, RBE 10,mix is also calculated within the MK model, but on the basis of measured y * values [25] . In the second approach, RBE 10,mix is calculated using the parameters of LQ fitting of survival curves of HSG cells with β fixed to 0.05 Gy −2 [25] . The profiles based on MCHIT simulations agree very well with the RBE 10,mix estimated on the basis of the two set of experimental data, see Figure 4 . In order to make such comparison, experimental values [25] corresponding to 1 H and 4 He were shifted in depth due to the difference of beam energies used in measurements and simulations.
A good agreement with data for 1 H, 4 He and 12 C suggests that this method can be also applied to 16 O beam. The distribution of RBE 10,mix for 16 O obtained on the basis of microdosimetry simulations with MCHIT is shown in Figure 4 
SOBP distributions of biological dose
The SOBP distributions of biological dose D bio for 1 H, 4 He, 12 C and 16 O are shown in Figure 5 . They are calculated for HSG cell as a product of physical dose calculated with MCHIT and RBE 10,mix obtained within the MK model on the basis of microdosimetric modeling with MCHIT. All four SOBP distributions presented in Figure 5 are 6 cm wide, and they are normalized to 1. at the plateau to Figure 4 . The distributions for all projectiles were rescaled to get the same value at the plateau.
The distribution of D bio for 12 C is characterized by the lowest values at the entrance channel. This helps to spare healthy tissues located in front of the target volume in treatments with 12 C. In contrast, the highest entrance dose is predicted for protons. However, the tail of the proton distribution beyond the distal edge of the plateau is negligible, while it is essential both for 12 C and 16 O. This indicates that the proton beam is the best option if very sensitive organs are located behind the tumor volume. The choice of ion species for each specific treatment can, in principle, provide an optimal ratio between the doses in the entrance and tail regions.
The distribution of D bio for 4 He demonstrates a favorably small dose at the tail region, while its entrance value is higher compared to 12 C. The biological dose delivered by 16 O to normal tissue is slightly increased both in front of the target volume and behind it compared to 12 C. From the analysis of D bio distributions one can conclude that 12 C is the best treatment option compared to 1 H, 4 He and 16 O, unless only a very low D bio is acceptable in the tail region. In the latter case protons become the best treatment option.
Distributions of cell survival fractions
The central part of our study is devoted to the comparison of survival fractions of cells S mix calculated as a function of depth in the water phantom, which are estimated for tissues of different radiosensitivity. This makes possible to evaluate the respective therapeutic outcome for such tissues.
The distributions of S mix calculated for cells (tissues) with (α/β) X−rays = 3.8. Gy, 2 Gy and 10 Gy after exposing them to 1 H, 4 He, 12 C and 16 O SOBP beams are shown in Figure 6 . Throughout this text the parameters for HSG cells were taken as α 0 = 0.13 Gy −1 and (α/β) X−rays = 3.8. Gy [25] . Hereafter the radiosensitivity of such tissues is considered as normal. This serves as a natural reference point for comparison with two other tissues with their parameters taken following Kase et al. [41] . The latter two cases correspond to early responding tissue (α 0 = 0.44 Gy −1 , (α/β) X−rays = 2 Gy) very sensitive to radiation and late responding tissue (α 0 = 0.04 Gy −1 , (α/β) X−rays = 10 Gy) which is radioresistant.
The dose applied to HSG cells (normal radiosensitivity) leads to their 10% survival at the target volume for all four beams. 4 He is the best one. In the case of early and late responding tissues, see Figure 6 , middle and bottom panels, the relation between the survival fractions estimated for 1 H, 4 He, 12 C and 16 O beyond the distal edge of the SOBP plateau are quite similar to the case of HSG cells. This is because of the fact that the dose in the tail region is defined by the presence of secondary fragments, which is essential for 12 C and 16 O beams. In the case of early responding tissues less than 5% of cells survive in the tumor volume, but their survival outside it is also unacceptably low (10-20%) . This means that in this case there are no advantages of charged particle therapy with respect to the intensity modulated radiation therapy (IMRT) with photons.
In the case of late responding tissues more cells (∼ 15%) survive in the tumor volume after the impact of 1 H, 4 He, 12 C and 16 O SOBP beams, see Figure 6 , bottom panel. 
Conclusions
In this work we presented our approach based on Monte Carlo simulations of microdosimetric spectra of monoenergetic beams of 1 H, 4 He, 12 C and 16 O in water. It provides y * values as input to the modified MK model [36] for calculating RBE 10,mix for HSG cells for SOBP distributions composed from monoenergetic beams of these projectiles. This method gives RBE 10,mix for 1 H, 4 He, 12 C which are in full agreement with RBE 10,mix also calculated within the MK model, but from measured y * [25] and RBE 10,mix calculated from the parameters of LQ fitting of survival curves of HSG cells [25] . This makes us confident in extending our approach to 16 O beams for which the respective data are not available. Our approach provides well-adjusted biological dose distributions for 1 H, 4 He, 12 C and 16 O with a very flat SOBP plateau. Thus basic properties of mixed radiation fields in treatments with these projectiles are emulated.
It is found that the shapes of RBE 10,mix profiles for 4 He, 12 C and 16 O are similar to each other, while the RBE 10,mix for protons is almost constant (∼ 1.) over the whole depth in water, excluding enhanced RBE 10,mix (∼ 1.2) after the distal edge of the SOBP plateau. Considerably lower RBE 10,mix • In the case of early responding tissues all four charged particle beams induce severe damage not only to the target volume, but also around it. Since in this case the region of high damage is not conformal to the target volume, the treatment with charged particles loses its advantages with respect to treatment with photons.
• In the case of tissues with normal radiosensitivity (HSG cells) 4 He and 12 C beams spare tissue in the entrance channel better than 1 H and 16 O ones.
• 4 He and 12 C nuclei are equally suitable for irradiation of tissues with normal and low radiosensitivity. The cell survival fractions calculated, respectively, for the entrance channel and target volume are similar for 4 He and 12 C.
• However, as soon as it is important to spare healthy tissues after the distal edge of the SOBP plateau, 4 H can be recommended due to the reduced nuclear fragmentation of these projectiles.
• No definitive advantages of 16 O with respect to 12 C were found, with the except of an enhanced impact of these heavier projectiles on radioresistant tumors.
In a recent work [42] the authors studied the possibility to spare healthy tissues by properly selecting ion species for therapy. In addition to 1 H, 4 He, 12 C they considered lithium, beryllium, boron and neon ions and calculated the dose to normal tissue delivered by these beams. However, the option of 16 O was not considered, while the Heidelberger Ionenstrahl-Therapiezentrum (HIT) in Heildeberg, Germany, provides 16 O beams of therapeutic energies [43, 11] in addition to 1 H, 4 He, 12 C. Treatments at this facility are performed presently only with protons and carbon ions, but 16 O can be also used following respective pre-clinical studies. In this sense our study complements the results of Remmes et al. [42] by considering 16 O beams, and also by comparing cell survival profiles in 1 H, 4 He, 12 C and 16 O treatments in addition to biological dose profiles. As suggested [44] , multi modal irradiations with various nuclei can be used for LET-painting. In this method high-LET radiation is used to boost the LET in a hypoxic sub-volume of the target (hypoxic compartments of the tumor). At the same time low-LET radiation is applied to the complementary target volume. Such combination may increase tumor control and reduce side effects. This means that a thorough evaluation of the physical properties and biological effectiveness of different beams is necessary before they can be applied in real treatments. Our approach can be also used for estimating RBE and cell survival fractions for 7 Li, 8 Be, 10 B and 14 N nuclei prior to planning radiobiological experiments with these beams.
